Thoroughbred Financial Services’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,218
| Closed | -$202K | – | 692 |
|
|
2024
Q3 | $202K | Sell |
3,218
-789
| -20% | -$49.5K | 0.01% | 627 |
|
|
2024
Q2 | $236K | Buy |
4,007
+967
| +32% | +$57K | 0.02% | 564 |
|
|
2024
Q1 | $242K | Sell |
3,040
-1,746
| -36% | -$139K | 0.02% | 415 |
|
|
2023
Q4 | $377K | Sell |
4,786
-4,856
| -50% | -$383K | 0.03% | 427 |
|
|
2023
Q3 | $673K | Buy |
9,642
+2,957
| +44% | +$206K | 0.07% | 283 |
|
|
2023
Q2 | $462K | Buy |
6,685
+217
| +3% | +$15K | 0.06% | 258 |
|
|
2023
Q1 | $480K | Sell |
6,468
-96
| -1% | -$7.12K | 0.07% | 250 |
|
|
2022
Q4 | $611K | Buy |
6,564
+509
| +8% | +$47.4K | 0.1% | 212 |
|
|
2022
Q3 | $577K | Buy |
6,055
+4
| +0.1% | +$381 | 0.11% | 186 |
|
|
2022
Q2 | $560K | Sell |
6,051
-77
| -1% | -$7.13K | 0.1% | 195 |
|
|
2022
Q1 | $620K | Buy |
6,128
+2,256
| +58% | +$228K | 0.1% | 198 |
|
|
2021
Q4 | $399K | Buy |
3,872
+4
| +0.1% | +$412 | 0.08% | 232 |
|
|
2021
Q3 | $328K | Buy |
3,868
+4
| +0.1% | +$339 | 0.08% | 229 |
|
|
2021
Q2 | $322K | Buy |
3,864
+160
| +4% | +$13.3K | 0.08% | 227 |
|
|
2021
Q1 | $278K | Buy |
3,704
+315
| +9% | +$23.6K | 0.08% | 221 |
|
|
2020
Q4 | $231K | Buy |
+3,389
| New | +$231K | 0.07% | 220 |
|
|
2020
Q1 | – | Sell |
-2,762
| Closed | -$205K | – | 253 |
|
|
2019
Q4 | $205K | Sell |
2,762
-2,533
| -48% | -$188K | 0.07% | 236 |
|
|
2019
Q3 | $334K | Buy |
5,295
+100
| +2% | +$6.31K | 0.13% | 171 |
|
|
2019
Q2 | $283K | Sell |
5,195
-176
| -3% | -$9.59K | 0.11% | 155 |
|
|
2019
Q1 | $290K | Sell |
5,371
-1,284
| -19% | -$69.3K | 0.12% | 176 |
|
|
2018
Q4 | $436K | Buy |
+6,655
| New | +$436K | 0.21% | 110 |
|